Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Simultaneous Quantitative Determination of 9 Blood Components in Suanzaoren Water Extract

A technology for quantitative determination and blood components, applied in measuring devices, material separation, and analysis of materials, can solve the problems of unfavorable pharmacokinetic research of traditional Chinese medicine, long analysis time, low analytical sensitivity, etc., and achieve comprehensive pharmacokinetic research , Shorten the analysis time and improve the detection sensitivity

Active Publication Date: 2021-07-02
汉方萃取生物科技(海南)股份有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The present invention is in order to solve the low analysis sensitivity of HPLC-UV in the quantitative analysis of the components in the blood of Jujube Seed at the present stage, it is not suitable for analyzing the trace components in the blood plasma, and the analysis time is too long; although LC-MS / MS has high measurement sensitivity, it only Applied to the determination of the pharmacokinetics of a single component, which is not conducive to the study of the pharmacokinetics of traditional Chinese medicine, a method for the simultaneous quantitative determination of 9 blood components in the water extract of Suanzaoren is provided, and Application of Oral Administration in the Pharmacokinetics of Normal and PCPA Insomnia Model Rats

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Simultaneous Quantitative Determination of 9 Blood Components in Suanzaoren Water Extract
  • Simultaneous Quantitative Determination of 9 Blood Components in Suanzaoren Water Extract
  • Simultaneous Quantitative Determination of 9 Blood Components in Suanzaoren Water Extract

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1: A method for the simultaneous quantitative determination of 9 blood components in the water extract of Suanzaoren, using the UHPLC-QExactive Orbitrap HR / MS method to quantitatively determine 9 active ingredients in the water extract of Suanzaoren: black medicine Alkaline, magnolialine, weixining, spinosin, flavin, kaempferol-3- O -Rutinoside, 6 ''' - Feruloyl spinosin, jujube saponin A and jujube saponin B; the specific steps are as follows:

[0028] (1) Preparation of a single stock solution of a reference substance: Accurately weigh the reference substances respectively, add the initial mobile phase of the chromatography analyzed by UHPLC-Q ExactiveOrbitrap HR / MS, and prepare 2.032 mg / mL of aconitine and 1.130 mg / mL of magnolialine The stock solution of single reference substance was prepared by adding methanol to Weicaining 2.184 mg / mL, spinosin 2.016 mg / mL, flavin 1.972 mg / mL, kaempferol-3- O - Rutinoside 2.058 mg / mL, 6 ''' - A single reference substan...

Embodiment 2

[0038] Embodiment 2: methodological investigation

[0039] 1. Specificity test: the blank plasma, blank plasma plus working solution, and drug-containing plasma from 6 rats from different sources were processed and analyzed according to the conditions in Example 1. Compare the chromatograms of the three, and observe whether there is interference in the blank plasma at the peak positions of the components to be tested and the internal standard. The result is as figure 1 As shown, the retention times of the components to be tested and the internal standard were respectively: 3.23 min for asteroidine, 4.12 min for magnolialine, 2.85 min for weicaining, 6.13 min for spinosin, 6.87 min for flavin, and 6.87 min for kaempferol-3 - O - Rutinoside 7.37 min, 6 ''' - Feruloyl spinosin 8.14 min, jujuboside A 10.76 min, juboside B 11.14 min, palmatine hydrochloride 10.22 min, daidzin 4.60 min, astragaloside 4 11.10 min. There was no interference in the blank plasma corresponding to th...

Embodiment 3

[0052] Example 3: Pharmacokinetic determination of 9 components in rat plasma after oral administration of jujube seed aqueous extract in normal and PCPA insomnia model rats

[0053] (1) Preparation of Suanzaoren water extract: take about 500 g of Suanzaoren decoction pieces, crush (60% pass through No. 1 Pharmacopoeia sieve), accurately weigh, add 10 times the amount of water, soak for 30 min, heat to boiling, and reflux extraction 2 h, filter, add 8 times the amount of water to the filter residue, heat and reflux for extraction for 2 h, filter, and combine the filtrates; concentrate under reduced pressure to 0.5 g / mL (crude drug amount), freeze-dry, and dissolve in water when used.

[0054] (2) Animal experiments and collection of plasma samples: healthy male SD rats, weighing 280±20 g, provided by Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. The rats were randomly divided into two groups, the normal group and the model group, with 6 rats in each group. Th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of in vivo metabolism research of Chinese patent medicines. In order to solve the problem that HPLC-UV sensitivity is low for too long in the quantitative analysis of jujube seeds entering the blood, it is not suitable for analyzing trace components in plasma; LC-MS / MS is only used for the determination of a single component. The pharmacokinetics of traditional Chinese medicine is not conducive to the study of pharmacokinetics of traditional Chinese medicine. A method for the simultaneous quantitative determination of 9 blood components in the water extract of Suanzaoren is provided. UHPLC‑Q Exactive Orbitrap HR / MS was used to simultaneously quantitatively determine nine blood components in jujube seed water extract; to improve detection sensitivity and shorten analysis time; to achieve simultaneous quantification of three polar compounds of flavonoids, saponins and alkaloids Analysis; provide analytical technical support for the pharmacokinetic study of Suanzaoren in normal and PCPA insomnia model rats, and provide reference for simultaneous quantitative analysis of other oral Chinese medicines with multiple components.

Description

technical field [0001] The invention belongs to the technical field of in vivo metabolism research of Chinese patent medicines, and in particular relates to a simultaneous quantitative determination method for nine blood-entering components in water extracts of jujube seeds. Background technique [0002] Ziziphus jujube is a plant of Rhamnaceae Ziziphus jujuba Mill. var. spinosa (Bunge) The dry and mature seeds of Huex H. F. Chou have the effects of nourishing the heart and nourishing the liver, calming the mind, calming the mind, suppressing sweat, and promoting body fluid. It is the first choice for clinical treatment of insomnia. Modern pharmacological studies have shown that total saponins, total flavonoids, and total alkaloids in Suanzaoren are the main active ingredients for sedation and hypnosis. [0003] As we all know, the absorption of active ingredients of traditional Chinese medicine into the blood is the premise of its curative effect, and multi-component, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06
Inventor 闫艳张敏杜晨晖张福生秦雪梅
Owner 汉方萃取生物科技(海南)股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products